Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Ataxia
  • >
  • Still leery about animal deaths, FDA lifts a full hold on Friedreich’s ataxia drug — but there’s a big condition – Endpoints News

Still leery about animal deaths, FDA lifts a full hold on Friedreich’s ataxia drug — but there’s a big condition – Endpoints News

Friday, 16 September, 2022

Still leery about animal deaths, FDA lifts a full hold on Friedreich’s ataxia drug — but there’s a big condition – Endpoints News

Little Larimar Therapeutics has finally worked its way out of regulatory limbo.

Kind of.

The biotech reported that the FDA has lifted its full clinical hold on CTI-1601 in Friedreich’s ataxia, imposed 16 months ago. And they’ve replaced it with a partial hold.

According to a statement from the company, the FDA is greenlighting a 25 mg cohort of a Phase II study in FA.

Read more at: https://endpts.com/still-leery-about-animal-deaths-fda-lifts-a-full-hold-on-friedreichs-ataxia-drug-but-theres-a-big-condition/

Categories :
  • Ataxia
  • Latest Headlines
Socials :

Recent posts